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Improving Survival for Patients With High-Risk Congenital 
Diaphragmatic Hernia by Using Extracorporeal 
Membrane Oxygenation 
By F.H.J.M. vd Staak, A.F.J. de Haan, W.B. Geven, W-H. Doesburg, and C. Festen 
NJmegen, The Netherlands 
0 The benefit of extracorporeal membrane oxygenation 
(ECMO) in cases of high-risk congenital diaphragmatic hernia 
(CDH) was studied by comparing pre-ECMO (1987-1990) and 
post-ECMO (1991-1994) 3-month survival statistics. Fifty-five 
CDH patients who presented in respiratory distress within 6 
hours after birth were referred-18 in the pre-ECMO era and 
37 in the ECMO era. During the entire study period (Decem- 
ber 1987 through July 1994) the patients were treated by the 
same protocol of preoperative stabilization and delayed 
surgery; the only difference was the addition of ECMO 
beginning in January 1991. The patients were stratified 
based on the response to conventional treatment: 1, no 
response (irretrievable); 2, stable; 3, unstable. The 3-month 
survival rate for the unstable neonates (who could not be 
stabilized by conventional therapy) improved from 0% (0 of 
9) in the pre-ECMO era to 61% (11 of 18) in the ECMO era 
(P = ,004). This highly significant difference shows that ECMO 
is a very valuable addition to the management of high-risk 
CDH patients whose conditions remain unstable despite 
maximal conventional therapy. 
Copyright 0 1995 by W.B. Saunders Company 
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D ESPITE ADVANCES in neonatal care, includ- ing prenatal diagnosis, neonatal transport, inten 
sive care treatment, anesthesiology, and surgery, the 
mortality rate among infants with congenital diaphrag- 
matic hernia (CDH), treated by conventional ventila- 
tory management and pharmacological support, re- 
mains high. The reported mortality rate for high-risk 
patients who have symptoms within 6 hours after 
birth ranges from 29% to 80%.le9 Extracorporeal 
membrane oxygenation (ECMO) was introduced as a 
therapy for newborns with respiratory failure unre- 
sponsive to maximal conventional treatment and may 
be used to support neonates who have respiratory 
distress caused by CDH.l”-12 
A number of investigators have reported success in 
treating CDH with ECM0.2-4J3-16 However, others 
have not seen improvement with use of ECM0.17Js 
According to the Extracorporeal Life Support Orga- 
nization (ELSO) registry, the survival rate for CDH 
patients treated by ECMO is 58%.19 This suggests 
that ECMO has no significant impact on the survival 
of newborns with high-risk CDH. 
In the present report we evaluate the role of 
ECMO in the management of CDH at our institution. 
MATERIALS AND METHODS 
All patients with CDH who were symptomatic within 6 hours 
after birth and who were referred between December 1987 and 
July 1994 were included in the study. All patients were treated by a 
protocol of delayed surgery after preoperative stabilizationss 
When ECMO became available in our institution (in January 
1991), it was incorporated into this protocol for CDH, whether 
preoperativelyor postoperatively. ECMO was offered after conven- 
tional ventilatory and medical management had failed, if the 
patient fulfilled the entry criteria for ECMO, if there were no 
contraindications for ECMO, and if parental consent was ob- 
tained. No infant in this study was excluded from ECMO support 
on the basis of failure to achieve a minimum Paoz before the 
institution of ECMO. 
Venoarterial ECMO was used as previously described by Bar- 
tlett et al.tz If ECMO was required for preoperative stabilization, 
the diaphragmatic defect was repaired during ECMO, at the end of 
the run, if the patient could be weaned from ECMO support.2o 
ECMO was discontinued when respiratory failure resolved (gas 
exchange requiring PIP of less than 30, ventilator rates of less than 
40, and FIO~ of less than 0.50) or when a complication arose that 
required cessation of ECMO (such severe bleeding complications 
rendering a contraindication to continued heparinization). Sur- 
vival is defined as “alive at the age of 3 months.” Survival statistics 
were compared for two time periods: (1) December 1987 through 
December 1990, when ECMO was not available and all children 
were treated with conventional ventilatory support and pharmaco- 
logical management (the pre-ECMO era, n = 18) and (2) January 
1991 through July 1994, when ECMO was available and was used if 
conventional treatment failed (the ECMO era, n = 37). 
The children were classified into the three groups described 
below. 
“I~et~evable”patients. These patients were (1) newborns with 
severe respiratory distress, noted immediately after birth, in whom 
a reasonable or normal gas exchange was never reached, despite 
endotracheal intubation and artificial ventilation, and who died 
within 2 hours after birth, before ECMO could be initiated, (2) 
newborns who died before or during transportation (pre-ECMO 
era, n = 1; ECMO era, n = 7), or (3) newborns with a severe 
congenital anomaly (especially chromosomal) for whom not all 
therapeutic modalities were offered (pre-ECMO era, n = 1). 
Conventionally stabilized patients. These were newborns with 
high-risk CDH, who recovered well by (maximal) conventional 
treatment and who underwent surgical repair of their diaphrag- 
matic defect after conventional stabilization. They never met 
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ECMO-entry criteria before repair of their diaphragmatic defect 
(pre-ECMO era, n = 7; ECMO era, n = 12). 
UnstubZe patients. These were newborns with high-risk CDH, 
and who could not be stabilized by maximal conventional treatment 
and who met one or more ECMO-entry criteria (pre-ECMO era, 
n = 9; ECMO era, n = 18). The patients in this category were 
subdivided into those who did (a) or did not (b) receive ECMO 
support. 
We made this stratification because we wanted to evaluate the 
effect of ECMO on survival. The irretrievable patients were in such 
distress that ECMO could not be initiated before death or before 
severe brain damage had occurred. In these circumstances any 
therapy, which ever applied, is doomed for failure. The availability 
of ECMO equipment had no effect on survival, neither in this 
group nor in the conventionally stabilized patients. Because no 
patient in the latter category met the ECMO-entty criteria and 
nearly all patients survived, ECMO is not a therapeutic option for 
this group. Thus, only in the unstable patients could the effect of 
the availability of ECMO equipment be measured. For compari- 
sons of survival rates, the two-sided Fisher’s Exact test was used. 
RESULTS 
Fifty-five newborns with high-risk CDH were evalu- 
ated-18 in the pre-ECMO era (Fig 1) and 37 in the 
ECMO era (Fig 2). 
One patient in the pre-ECMO era was categorized 
as “irretrievable” because of a chromosomal anomaly. 
One neonate in the first period and seven in the latter 
period were irretrievable; they died of severe respira- 
tory distress shortly after birth, before ECMO could 
be or could have been initiated. In this category, the 
average transcutaneous oxygen saturation was 64%, 
the average PaoZ was 4.5 kilo-Pascals (kPa) (34 mm 
Hg), the average PacoZ was 10.9 kPa (82 mm Hg), and 
the average pH was 6.89. 
In the pre-ECMO period, preoperative stabiliza- 
tion could be achieved by conventional treatment 
(CT) in seven patients (Fig 1). In these patients the 
diaphragmatic defect could be repaired, and six 
survived. Nine patients could not be stabilized conven- 
tionally; none of them had surgical repair, and none 
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Fig I. Progress of 18 high-risk CDH patients in the pre-ECMO ere 
(December 1987 through December 1990). 
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Fig 2. Progress of 37 high-risk CDH patients in the ECMO ers 
(January 1991 through July 1994). 
survived. These patients would have qualified for 
ECMO support had it been available. 
Since ECMO became available at our institution, 
preoperative stabilization by conventional therapy 
could be achieved in 12 patients (Fig 2). All 12 had 
repair of their diaphragmatic defect, and 10 survived, 
although postoperative ECMO support was required 
for one of them. 
Eighteen cases were refractory to conventional 
management and were considered for ECMO treat- 
ment. In two of the patients, ECMO therapy was not 
instituted; in one patient ECMO treatment was 
refused by the parents, and in the very first patient, 
who was an ECMO candidate, we thought it was 
better to repair the diaphragmatic defect before 
initiation of ECMO, during preparation of the ECMO 
circuit. Both patients died. Thus, in 16 patients 
ECMO was used for preoperative stabilization. In 
one patient the ECMO treatment was discontinued 
because of severe cerebral bleeding, and the patient 
died without having repair of the diaphragmatic 
defect. The other 15 patients could be weaned from 
ECMO, and all had repair of their diaphragmatic 
defect during ECMO, late in the ECMO run. Eleven 
survived. The four deaths after ECMO were related 
to multiorgan failure (n = l), severe lunghypoplasia 
(n = l), or recurrent persistent pulmonary hyperten- 
sion (n = 2). The demographic data of the different 
patient groups, for the two time periods, are reported 
in Table 1. 
The overall survival rate was 33% in the pre- 
ECMO era and 57% in the ECMO era. Excluding the 
irretrievable patients in both periods, the survival rate 
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Table I. Demographic Data for Both Time Periods 
Conventionally 
Irretrievable Stable Unstable 
Pre-ECMO ECMO Pre-ECMO ECMO Pre-ECMO ECMO 
Male:female ratio 
Gestational age (wk) 
Average 
Range 
Birth weight (g) 
Average 
Range 
Apgar scores (average & range) 
1 min 
5 min 
Side 
Left:right 
0:2 4:3 3:4 5:7 5:4 IO:8 
42.0 
(42-42) 
38.7 
(36-42) 
38.5 
(34-41) 
38.0 
(34-42) 
40.3 
(38-42) 
39.8 
(34-42) 
2,850 
(2,300-3,400) 
2,740 
(1,500-3,460) 
2,780 
(I ,480-3,500) 
2,660 
(1,760-3,740) 
3,160 
(2,450.3,930) 
3,410 
(2,560-4,175) 
1.5 (l-2) 
2.5 (l-4) 
1.8 (l-4) 
3.8 (2-6) 
7.4 (4-9) 
6.0 (4-9) 
5.0 (3-9) 
6.7 (4-10) 
4.5 (l-9) 
4.8 (l-8) 
3.2 (O-6) 
4.8 (O-8) 
2:o 5:2 5:2 10:2 8:l 16:2 
NOTE: Pre-ECMO era, December 1987 through December 1990; ECMO era, January 1991 through July 1994. 
was 38% in the first period and 70% in the second 
period (Fisher’s Exact test, P = .08). The survival rate 
among infants who could be stabilized conventionally 
was 86% in the pre-ECMO era and 83% in the 
ECMO era (Fisher’s Exact test, P > SO). The sur- 
vival rate for the conventionally not-stabilized pa- 
tients was 0% in the first period and 61% in the latter 
period (Fisher’s Exact test, P = .004). 
Ultimately, 11 of the 16 unstable patients who were 
supported by ECMO survived (69%), whereas no 
unstable patient survived without ECMO support 
(Fisher’s Exact test, P = .0006). 
DISCUSSION 
In this report we present our experience with 48 
severely afflicted infants with CDH, who were treated 
according to a protocol of preoperative stabilization 
and delayed surgery.5-9 This protocol was unchanged 
during the entire period of the study. 
The only difference in management was the addi- 
tion of ECMO for (pre- or postoperative) stabiliza- 
tion since January 1991. This offers the opportunity to 
evaluate the role of ECMO in the treatment of 
high-risk CDH, by dividing the patients into two 
groups with respect to ECMO availability (pre- 
ECMO and ECMO). 
The overall survival rate for high-risk CDH pa- 
tients increased from 33% in the pre-ECMO era to 
57% in the ECMO era. This means improvement, but 
the difference is not significant statistically. For this 
reason, and because infants with CDH have gained 
less advantage by ECMO than have infants with 
respiratory distress from other causes,19 the benefits 
of ECMO support for high-risk CDH patients remain 
controversial.z-4,13-18 However, to assess the impact of 
ECMO we must compare identical populations with 
respect to demographic data as well as severity of 
disease, because differences in the composition of the 
groups can influence the outcome. Over the past 
decade, many attempts have been made to grade the 
seriousness of the disease and to establish criteria by 
which survival could be predicted or by which patients 
could be considered for a certain kind of (aggressive) 
therapy. Parameters used, are the interval from birth 
until the appearance of symptoms; the occurrence of 
a “honeymoon period”21; and blood-gas analysis, with 
and without linkage with ventilator settings and time, 
eg, AaDo2, oxygenation index, and ventilation index 
linked with Paco2.9,22-28 
Nevertheless, all criteria appear to be unreliable; 
there is no single, simple objective criterion by which 
the clinical course and outcome can be predicted and 
by which the two interrelated pathophysiological 
mechanisms (lung hypoplasia and pulmonary hyper- 
tension) can be unraveled.4314-16,2se31 In the literature 
there is agreement that neonates who are in respira- 
tory distress within 6 hours after birth constitute a 
high-risk group. We divided this high-risk group into 
three subgroups, based on the clinical course at the 
time (maximal) conventional treatment was applied. 
Some patients are considered to be irretrievable 
because they are unable to attain satisfactory oxygen- 
ation despite maximal conventional therapy immedi- 
ately begun after birth. These patients have not even 
the ability to meet standard ECMO criteria because 
of lack of time. They die before ECMO can be 
initiated. Most investigators report only a few such 
cases, but these comprise 19% of the CDH patients 
referred to our institution in the ECMO era. This 
group reflects the impact of the availability of ECMO 
on referral patterns, but this group has a negative 
influence on the overall survival rate, which can lead 
to misinterpretation of the efficacy of ECMO treat- 
ment in CDH patients. The amount of functional lung 
tissue in these infants is inadequate for survival. Since 
January 1991, 14 infants were transferred, pre- or 
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postnatally, specifically for ECMO. Two could be 
treated conventionally, nine received ECMO sup- 
port, and three died before ECMO could be initiated. 
In other patients, respiratory distress can be allevi- 
ated by immediate applied conventional therapy. 
Some such patients can be stabiIized by conventional 
ventilator-y management and never meet ECMO- 
entry criteria. Others cannot be stabilized convention- 
ally and meet standard ECMO criteria. Only in this 
latter group of patients can a reliable judgment be 
made of the benefit of ECMO for CDH. 
In both periods the conventionally stabilized pa- 
tients and the unstable patients were comparable 
with respect to gestational age, birth weight, gender 
distribution, Apgar scores, and side of the defect 
(Table 1). As might be expected, the survival rate of 
category II patients was virtually the same in both 
periods-86% in the pre-ECMO era and 83% in the 
ECMO era. However, the survival rate for unstable 
patients is significantly better in the ECMO era than 
it was beforehand (61% v 0%). Because the groups 
are comparable for both time periods, and because 
the only difference in treatment is the addition of 
ECMO in the latter period, the better survival rate 
can be attributed completely to ECMO therapy. 
VD STAAK ET AL 
All children who had stabilization with ECMO 
survived; this represents an increase in the overall 
survival rate. All unstable children who met ECMO 
entry criteria died without ECMO support. 
The fact that all children who met ECMO criteria 
died without ECMO support is in accordance with 
the aim of ECMO as a treatment of last resort, ie, 
only applied in critically ill infants, whose projected 
mortality rate was more than 80%. 
From the experience with high-risk CDH patients 
treated in our institution by a protocol of delayed 
surgery after preoperative stabilization, with and 
without ECMO, we draw the following conclusions. 
(1) The overall mortality rate among high-risk CDH 
patients is still high. (2) Some infants have such 
severe lung hypoplasia that they were unable to attain 
sufficient gas exchange to bridge the time until 
initiation of ECMO. (3) Use of ECMO support is an 
improvement in our therapy protocol for cases that 
cannot be stabilized by conventional treatment; the 
survival rate associated with ECMO (61%) is signifi- 
cantly better than that without ECMO (0%). (4) 
ECMO availability changed the referral pattern; 
increasingly sicker patients are seen, who previously 
would not have survived. 
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